At this time, posts about ABL Bio are rapidly increasing on portals and stock communities. Today, foreign investors have sold a net 75,428 shares of ABL Bio, and institutions have sold a net 15,000 shares, according to provisional data. ABL Bio is known as a specialized company developing biopharmaceuticals based on antibody therapeutics.

As of 12:30 PM on the 5th, ABL Bio's stock price is 37,250 KRW, up 1.78% from the previous day, with a trading volume of 8,313,721 shares, which is 276.58% of the average trading volume on the 5th. On August 4th, ABL Bio was a market issue with a "14% increase due to expectations for new bio drug development."

In addition to ABL Bio, posts by investors are also rapidly increasing for Mirae Asset Daewoo (006800), Genolution (225220), and Chong Kun Dang (185750).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing